A retrospective analysis of the role of proton pump inhibitors on colorectal cancer disease survival.

被引：0
|
作者：
Ramjeesingh, Ravi
Graham, Cassandra
Orr, Christine
Bricks, Corey Sean
Hopman, Wilma M.
Hammad, Nazik
机构：
[1] Queens Univ, Dept Oncol, Canc Ctr Southeastern Ontario, Kingston, ON, Canada
[2] Queens Univ, Dept Publ Hlth Sci, Kingston, ON, Canada
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2015年 / 33卷 / 15期
关键词：
D O I：
10.1200/jco.2015.33.15_suppl.e14517
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e14517
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Effects of proton pump inhibitors (PPIs) on FOLFOX and XELOX regimens in colorectal cancer (CRC).
    Wong, Grace
    Ha, Vincent
    Chu, Michael Patvin
    Dersch-Mills, Deonne
    Ghosh, Sunita
    Chambers, Carole
    Sawyer, Michael B.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [42] Proton Pump Inhibitors and Risk of Acute and Chronic Kidney Disease: A Retrospective Cohort Study
    Hart, Emily
    Dunn, Terry E.
    Feuerstein, Steven
    Jacobs, David M.
    PHARMACOTHERAPY, 2019, 39 (04): : 443 - 453
  • [43] Peptic ulcer disease in the era of proton pump inhibitors - a population analysis
    Chalasani, S.
    Rogers, A.
    Winters, D. C.
    BRITISH JOURNAL OF SURGERY, 2015, 102 : 32 - 32
  • [44] Role of Proton Pump Inhibitors on Severity and Outcome of Clostridium difficile Associated Disease
    Aravinthan, Aloysious
    Nikolic, Marko
    Dawwas, Muhammad F.
    Lee, Young-Mee
    GASTROENTEROLOGY, 2010, 138 (05) : S577 - S578
  • [45] ROLE OF PROTON PUMP INHIBITORS ON SEVERITY AND OUTCOME OF CLOSTRIDIUM DIFFICILE ASSOCIATED DISEASE
    Aravinthan, A.
    Nikolic, M.
    Lee, Y. M.
    GUT, 2009, 58 : A25 - A25
  • [46] Association between capecitabine efficacy and proton pump inhibitors in patients with stage II-III colorectal cancer: A retrospective multicenter study
    Fujii, H.
    Kitazume, Y.
    Uozumi, R.
    Iihara, H.
    Takahashi, M.
    Arai, T.
    Yoshizawa, T.
    Murachi, Y.
    Sato, Y.
    Mikami, T.
    Hashiguchi, K.
    Takahashi, K.
    Fujita, Y.
    Yamazaki, T.
    Hosokawa, Y.
    Morozumi, I.
    Tsuchiya, M.
    Yokoyama, A.
    Hashimoto, H.
    Yamaguchi, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S576 - S577
  • [47] Proton pump inhibitors and chronic kidney disease
    Kamal, Faisal
    Khan, Muhammad Ali
    Howden, Colin W.
    KIDNEY INTERNATIONAL, 2017, 92 (02) : 515 - 515
  • [48] Proton pump inhibitors: predisposers to Alzheimer disease?
    Fallahzadeh, M. K.
    Borhani-Haghighi, A.
    Namazi, M. R.
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2010, 35 (02) : 125 - 126
  • [49] Could proton pump inhibitors cause cancer?
    Rosch, Paul
    EXPERT REVIEW OF CLINICAL PHARMACOLOGY, 2014, 7 (02) : 109 - 110
  • [50] Repositioning of proton pump inhibitors in cancer therapy
    Lu, Zhen-Ning
    Tian, Bing
    Guo, Xiu-Li
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2017, 80 (05) : 925 - 937
12345